Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | 90,000 | reported | 31 Jan 2017 | tx 3+215,000 |
| Q32 Bio Inc. | 36,000 | reported | 23 Feb 2023 | tx 48+880,341−173,041 |
| NeuroMetrix, Inc. | 35,000 | reported | 01 Apr 2008 | tx 30+159,400−100,000 |
| Lyra Therapeutics, Inc. | 0 | reported | 14 May 2026 | tx 6+96,500−640 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | OTHER | Lyra Therapeutics, Inc. | 640 | 0.00 USD | |
| 14 May 2025 | GRANT_AWARD | Lyra Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Lyra Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Lyra Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Q32 Bio Inc. | 213,000 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Q32 Bio Inc. | 36,000 | 0.00 USD | deriv |
| 09 Jan 2023 | SALE | Q32 Bio Inc. | 3,729 | 1.39 USD | anomaly |
| 01 Jan 2023 | EXERCISE | Q32 Bio Inc. | 6,600 | — | |
| 01 Jan 2023 | EXERCISE | Q32 Bio Inc. | 6,930 | — | |
| 01 Jan 2023 | EXERCISE | Q32 Bio Inc. | 6,600 | 0.00 USD | deriv |
| 01 Jan 2023 | EXERCISE | Q32 Bio Inc. | 6,930 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | Q32 Bio Inc. | 21,000 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | Q32 Bio Inc. | 126,000 | 0.00 USD | deriv |
| 01 Jan 2022 | EXERCISE | Q32 Bio Inc. | 6,600 | — | |
| 05 Jan 2022 | SALE | Q32 Bio Inc. | 2,182 | 3.78 USD | anomaly |
| 01 Jan 2022 | EXERCISE | Q32 Bio Inc. | 6,600 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 08 Feb 2021 | SALE | Q32 Bio Inc. | 13,500 | 14.25 USD | |
| 08 Feb 2021 | EXERCISE | Q32 Bio Inc. | 13,500 | 0.64 USD | |
| 05 Feb 2021 | GRANT_AWARD | Q32 Bio Inc. | 122,000 | 0.00 USD | deriv |
| 05 Feb 2021 | GRANT_AWARD | Q32 Bio Inc. | 20,000 | 0.00 USD | deriv |
| 08 Feb 2021 | EXERCISE | Q32 Bio Inc. | 13,500 | 0.00 USD | deriv |
| 03 Feb 2020 | SALE | Q32 Bio Inc. | 12,000 | 16.16 USD | |
| 03 Feb 2020 | EXERCISE | Q32 Bio Inc. | 12,000 | 0.63 USD |